Literature DB >> 15885702

Diversity in hapten recognition: structural study of an anti-cocaine antibody M82G2.

Edwin Pozharski1, Aaron Moulin, Anura Hewagama, Armen B Shanafelt, Gregory A Petsko, Dagmar Ringe.   

Abstract

Antibodies against cocaine and other drugs of abuse are the basis for diagnostic tests for the presence of those drugs in human serum. The 1.7A resolution crystal structure of the anti-cocaine monoclonal antibody M82G2 in complex with cocaine is presented. This structure determination was undertaken to establish the stereochemical features in the antibody binding site that confer specificity for cocaine, and as part of an ongoing project to understand the rules that govern molecular recognition. The cocaine-binding site can be characterized topologically as a narrow groove on the protein surface. The antibody utilizes water-mediated hydrogen bonding, and cation-pi and stacking (pi-pi) interactions to provide specificity. Comparison with the previously published structure of the anti-cocaine antibody GNC92H2 shows that binding of a small ligand can be achieved in diverse ways, both in terms of a binding site structure/topology and protein-ligand interactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885702     DOI: 10.1016/j.jmb.2005.03.080

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  Modeling the catalysis of anti-cocaine catalytic antibody: competing reaction pathways and free energy barriers.

Authors:  Yongmei Pan; Daquan Gao; Chang-Guo Zhan
Journal:  J Am Chem Soc       Date:  2008-03-15       Impact factor: 15.419

2.  The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen.

Authors:  Jonathan M Wojciak; Norman Zhu; Karen T Schuerenberg; Kelli Moreno; William S Shestowsky; Masao Hiraiwa; Roger Sabbadini; Tom Huxford
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

3.  High-affinity pan-specific monoclonal antibodies that target cysteinyl leukotrienes and show efficacy in an acute model of colitis.

Authors:  Ashlee N King; Jonathan K Fleming; Stephanie S Knapik; Barbara Visentin; Jonathan M Wojciak; Tom Huxford
Journal:  J Lipid Res       Date:  2017-05-15       Impact factor: 5.922

4.  Structural analysis of free and liganded forms of the Fab fragment of a high-affinity anti-cocaine antibody, h2E2.

Authors:  Kemin Tan; Min Zhou; Angela J Ahrendt; Norma E C Duke; Nassif Tabaja; William J Ball; Terence L Kirley; Andrew B Norman; Andrzej Joachimiak; Marianne Schiffer; Rosemarie Wilton; P Raj Pokkuluri
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-11-05       Impact factor: 1.056

5.  A molecular model for cocaine binding by the immunotherapeutic human/mouse chimeric monoclonal antibody 2E2.

Authors:  Michael Lape; Stefan Paula; William J Ball
Journal:  Eur J Med Chem       Date:  2010-02-06       Impact factor: 6.514

6.  Active immunotherapy for the Treatment of Cocaine Dependence.

Authors:  Berma M Kinsey; Thomas R Kosten; Frank M Orson
Journal:  Drugs Future       Date:  2010-04-01       Impact factor: 0.148

7.  Biochemical and structural characterization of lysophosphatidic Acid binding by a humanized monoclonal antibody.

Authors:  Jonathan K Fleming; Jonathan M Wojciak; Mary-Ann Campbell; Tom Huxford
Journal:  J Mol Biol       Date:  2011-03-15       Impact factor: 5.469

8.  Crystal structures of a therapeutic single chain antibody in complex with two drugs of abuse-Methamphetamine and 3,4-methylenedioxymethamphetamine.

Authors:  Reha Celikel; Eric C Peterson; S Michael Owens; Kottayil I Varughese
Journal:  Protein Sci       Date:  2009-11       Impact factor: 6.725

9.  Chemoinformatic methods for predicting interference in drug of abuse/toxicology immunoassays.

Authors:  Matthew D Krasowski; Mohamed G Siam; Manisha Iyer; Anthony F Pizon; Spiros Giannoutsos; Sean Ekins
Journal:  Clin Chem       Date:  2009-04-02       Impact factor: 8.327

10.  Molecular similarity methods for predicting cross-reactivity with therapeutic drug monitoring immunoassays.

Authors:  Matthew D Krasowski; Mohamed G Siam; Manisha Iyer; Sean Ekins
Journal:  Ther Drug Monit       Date:  2009-06       Impact factor: 3.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.